-
Orbit Genomics Named Finalist in Startup Prize Focus on Health
Orbit Genomics is proud to announce that we have been named a finalist in the Startup Prize Focus on Health competition, an initiative that spotlights transformative innovation in healthcare and life sciences. This recognition highlights the impact and potential of our patented OrbiSeq™ platform, an AI-powered approach to transform diagnosis, treatment and prevention of complex…
-
Orbit Genomics Appoints Strategic Communications and Capital Markets Leader Julie Silber to Board of Directors
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Julie Silber to its Board of Directors. Silber brings over 25 years of experience in investor relations, capital markets, corporate strategy, and board advisory, with expertise in the diagnostics and life sciences sectors to support Orbit’s next phase of growth in precision…
-
Orbit Genomics At MassChallenege Midpoint Road Show
Orbit Genomics thanks the MassChallenge community for an incredible Midpoint Road Show in Dallas last week! The energy, insight, and support from mentors and partners was invaluable—but what stood out most was the camaraderie among the cohort.We are surrounded by an inspiring group of founders who are each tackling MASSive problems in healthcare—from early cancer…